LATEST NEWS
EXACT Therapeutics announces grant of core patent in the U.S.
EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients with locally advanced pancreatic cancer
EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial in liver metastases from colorectal cancer
EXACT Therapeutics announces grant of key patent covering non-invasive delivery of pharmaceuticals to the brain
Wall Street Journal:
New Ultrasound Therapy Could Help Treat Alzheimer’s, Cancer